Andreas H. Wagner

Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation

Andreas H. Wagner, Thomas Köhler, Uwe Rückschloss et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 516 citations

Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2018 · 425 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Coronary Unit +6

Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial

Raban Jeger, Ahmed Farah, Marc‐Alexander Ohlow et al. · The Lancet · 2020 · 243 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Drug-coated Balloons +6

17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells

Andreas H. Wagner, Marco R. Schroeter, Markus Hecker · The FASEB Journal · 2001 · 222 citations

Endothelial Cells, Nitric Oxide, Lipid Peroxidation +18

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans

Alexander T. Bauer, Jan Suckau, K Frank et al. · Blood · 2015 · 156 citations · Full text